1. Stocks
    2. /
  2. Telix Pharmaceuticals (ASX: TLX)
    3. /

Telix Pharmaceuticals (ASX: TLX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Telix Pharmaceuticals Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Telix Pharmaceuticals (ASX: TLX)
    Latest News

    A tattoed woman holds two fingers up in a peace sign.
    Healthcare Shares

    2 ASX stocks to buy today with $10,000

    | Samantha Menzies

    Analysts are positive about these shares.

    Read more »

    Multi-ethnic people looking at camera sitting at public place screaming, shouting and feeling overjoyed about their windfall, good news or sports victory.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    ASX shares finally reversed their losses today.

    Read more »

    Ecstatic woman looking at her phone outside with her fist pumped.
    Share Gainers

    Why Megaport, Suncorp, Telix, and Westpac shares are pushing higher today

    | James Mickleboro

    These shares are having a strong session on hump day. But why?

    Read more »

    Woman stepping on big rock in a lake.
    Healthcare Shares

    After falling 29% in August, is this ASX 200 star the best share to buy today?

    | Aaron Bell

    After a rough August, this could be a stock to target. 

    Read more »

    A man clenches his fists in excitement as gold coins fall from the sky.
    Share Gainers

    Why 29Metals, Cobram Estate, Ora Banda, and Telix shares are rising today

    | James Mickleboro

    These shares are having a good session on Tuesday. But why?

    Read more »

    Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
    Healthcare Shares

    Telix share price lifts off on big US FDA news

    | Bernd Struben

    ASX investors are piling into Telix shares today following a new FDA agreement.

    Read more »

    A man sitting at his dining table looks at his laptop and ponders the CSL balance sheet and the value of CSL shares today
    Broker Notes

    4 ASX All Ords shares just upgraded to strong buy ratings

    | Bronwyn Allen

    These ASX stocks were upgraded to a consensus strong buy rating on the CommSec platform last month.

    Read more »

    Two brokers pointing and analysing a share price.
    Share Market News

    Can you guess the best and worst performing sectors during earnings season?

    | Laura Stewart

    Investors looking to reposition their portfolios may want to read on.

    Read more »

    Businessman in a barrel plunges down a waterfall
    Share Fallers

    The worst 3 ASX 200 stocks to buy and hold in August unmasked

    | Bernd Struben

    Investors sent these three ASX 200 shares plunging in August. But why?

    Read more »

    A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
    Broker Notes

    These ASX 200 shares could rise 25% to 60%

    | James Mickleboro

    Brokers are tipping these shares to deliver outsized returns for investors.

    Read more »

    Man looking happy and excited as he looks at his mobile phone.
    Healthcare Shares

    Down 53%! Bell Potter says this beaten down ASX 200 stock is a buy

    | James Mickleboro

    The broker sees recent weakness as a buying opportunity for investors.

    Read more »

    A young man punches the air in delight as he reacts to great news on his mobile phone.
    Broker Notes

    Brokers name 3 ASX shares to buy today

    | James Mickleboro

    Here's why brokers are feeling bullish about these three shares this week.

    Read more »

    Frequently Asked Questions

    No, Telix does not pay dividends at this time. 

    Telix Pharmaceuticals Ltd listed on the ASX on 15 November 2017.

    TLX ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Telix Pharmaceuticals

    Telix Pharmaceuticals Ltd (ASX: TLX) is a commercial-stage biopharmaceutical company focused on the ongoing development of diagnostic and therapeutic ('theranostic') products using targeted radiation. This process treats cancerous or diseased cells, an alternative approach to many cancer therapies which also attack healthy tissue at the same time.

    Telix has received global regulatory approvals from the Australian Therapeutic Goods Administration (TGA), the US Food and Drug Administration (FDA), and Health Canada for its prostate cancer imaging agent Illuccix. It is working to get Illuccix approved for sale in the UK and Europe. 

    The company also has more than 20 clinical trials underway worldwide. Telix's research and development is focused on prostate, renal (kidney), glioblastoma (brain), and hematologic (bone marrow conditioning) cancers, as well as rare diseases. The company is headquartered in Australia with offices in Belgium, Japan, Switzerland, and the United States. 

    Profile

    since

    Note